BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6086678)

  • 1. Verapamil enhances the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin and antitransferrin receptor with Pseudomonas exotoxin.
    Akiyama S; Gottesman MM; Hanover JA; Fitzgerald DJ; Willingham MC; Pastan I
    J Cell Physiol; 1984 Sep; 120(3):271-9. PubMed ID: 6086678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement by a synthetic isoprenoid of the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin.
    Akiyama S; Shiraishi N; Yoshimura A; Nakagawa M; Yamaguchi T; Shimada T; Kuwano M
    Biochem Pharmacol; 1987 Mar; 36(6):861-8. PubMed ID: 3494452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioridazine enhances lysosomal accumulation of epidermal growth factor and toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin.
    Kuratomi Y; Akiyama S; Ono M; Shiraishi N; Shimada T; Ohkuma S; Kuwano M
    Exp Cell Res; 1986 Feb; 162(2):436-48. PubMed ID: 3484705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation by a biscoclaurine alkaloid, cepharanthine, of the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin in HeLa cells.
    Shiraishi N; Shimada T; Hagino Y; Kohno K; Kobayashi M; Kuwano M; Akiyama S
    Cancer Res; 1988 Mar; 48(5):1307-11. PubMed ID: 3257717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of toxicity of antitransferrin receptor antibody-Pseudomonas exotoxin conjugates by adenovirus.
    FitzGerald DJ; Trowbridge IS; Pastan I; Willingham MC
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4134-8. PubMed ID: 6306663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of calcium antagonists on intracellular transport of epidermal growth factor and the conjugate of epidermal growth factor with pseudomonas exotoxin].
    Akiyama S
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):660-8. PubMed ID: 3920969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epidermal growth factor-ricin A chain (EGF-RTA)-resistant mutant and an epidermal growth factor-Pseudomonas endotoxin (EGF-PE)-resistant mutant have distinct phenotypes.
    Banker DE; Pastan I; Gottesman MM; Herschman HR
    J Cell Physiol; 1989 Apr; 139(1):51-7. PubMed ID: 2496133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterization of human KB cell lines resistant to epidermal growth factor: Pseudomonas exotoxin conjugates.
    Amano F; Pastan I; Gottesman MM
    J Cell Physiol; 1988 Jun; 135(3):527-32. PubMed ID: 3260900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-transferrin receptor antibody linked to Pseudomonas exotoxin as a model immunotoxin in human ovarian carcinoma cell lines.
    Pirker R; FitzGerald DJ; Hamilton TC; Ozols RF; Willingham MC; Pastan I
    Cancer Res; 1985 Feb; 45(2):751-7. PubMed ID: 2981613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas exotoxin A-epidermal growth factor (EGF) mutant chimeric protein as an indicator for identifying amino acid residues important in EGF-receptor interaction.
    Shiah HS; Chen TY; Chang CM; Chow JT; Kung HJ; Hwang J
    J Biol Chem; 1992 Nov; 267(33):24034-40. PubMed ID: 1429738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of human KB cell lines resistant to epidermal growth factor-Pseudomonas exotoxin conjugates.
    Lyall RM; Hwang JL; Cardarelli C; FitzGerald D; Akiyama S; Gottesman MM; Pastan I
    Cancer Res; 1987 Jun; 47(11):2961-6. PubMed ID: 3494506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A target-specific chimeric toxin composed of epidermal growth factor and Pseudomonas exotoxin A with a deletion in its toxin-binding domain.
    Liao CW; Hseu TH; Hwang J
    Appl Microbiol Biotechnol; 1995 Jul; 43(3):498-507. PubMed ID: 7632400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas exotoxin-anti-TAC. Cell-specific immunotoxin active against cells expressing the human T cell growth factor receptor.
    FitzGerald DJ; Waldmann TA; Willingham MC; Pastan I
    J Clin Invest; 1984 Sep; 74(3):966-71. PubMed ID: 6432853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor-dependent growth of human KB cells in a defined medium and altered growth factor requirements of KB mutants resistant to EGF-Pseudomonas exotoxin conjugates.
    Amano F; Gottesman MM; Pastan I
    J Cell Physiol; 1988 Jun; 135(3):502-8. PubMed ID: 3294236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation.
    Paria BC; Elenius K; Klagsbrun M; Dey SK
    Development; 1999 May; 126(9):1997-2005. PubMed ID: 10101133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An EGF-pseudomonas exotoxin A recombinant protein with a deletion in toxin binding domain specifically kills EGF receptor bearing cells.
    Lee CH; Lee EC; Tsai ST; Kung HJ; Liu YC; Hwang J
    Protein Eng; 1993 Jun; 6(4):433-40. PubMed ID: 8332601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of transferrin receptor antibody, transferrin receptor antibody bound to Pseudomonas exotoxin and transforming growth factor-alpha bound to Pseudomonas exotoxin on human tenon's capsule fibroblast proliferation.
    Smyth RJ; Kitada S; Lee DA
    J Ocul Pharmacol; 1992; 8(1):83-90. PubMed ID: 1402298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heparin-binding domain of heparin-binding EGF-like growth factor can target Pseudomonas exotoxin to kill cells exclusively through heparan sulfate proteoglycans.
    Mesri EA; Ono M; Kreitman RJ; Klagsbrun M; Pastan I
    J Cell Sci; 1994 Sep; 107 ( Pt 9)():2599-608. PubMed ID: 7844173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxin-epidermal growth factor conjugate.
    Seth P; Fitzgerald DJ; Willingham MC; Pastan I
    J Virol; 1984 Sep; 51(3):650-5. PubMed ID: 6332200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant KB cells with decreased EGF receptor expression: biochemical characterization.
    Hwang J; Richert N; Pastan I; Gottesman MM
    J Cell Physiol; 1987 Oct; 133(1):127-34. PubMed ID: 2444605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.